We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced...
TIDMAGL RNS Number : 3600A Angle PLC 22 January 2024 For immediate release 22 January 2024 ANGLE plc ("the Company") REVIEW PAPER ON MOLECULAR ANALYSIS OF PARSORTIX CTC HARVEST HIGHLIGHTS POTENTIAL UT...
1a. Identity of the issuer or the ANGLE plc underlying issuer of existing shares to which voting rights are attached (ii) ...
(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services. Shares in the Surrey...
By Ian Walker Angle PLC shares rose as much as 41% in early trade after the company said that DNA molecular analysis from cancer patient blood samples provides insight into the progression and treatme...
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, i...
Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study w...
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, i...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- Premier African Minerals Ltd - Africa-foc...
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology, i...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1 | -6.55737704918 | 15.25 | 15.25 | 14.25 | 657592 | 14.88370688 | DE |
4 | -4.5 | -24 | 18.75 | 18.75 | 14.25 | 978931 | 16.19727585 | DE |
12 | 3 | 26.6666666667 | 11.25 | 37.5 | 11.1 | 3965206 | 22.70612201 | DE |
26 | -2 | -12.3076923077 | 16.25 | 37.5 | 9.125 | 2674895 | 19.00233099 | DE |
52 | -7.25 | -33.7209302326 | 21.5 | 37.5 | 9.125 | 2086055 | 18.5037172 | DE |
156 | -70.25 | -83.1360946746 | 84.5 | 163.5 | 9.125 | 1347479 | 47.15647823 | DE |
260 | -41.25 | -74.3243243243 | 55.5 | 163.5 | 9.125 | 1030229 | 50.02450661 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |